A gene signature of chemo-immunization to predict outcome in patients with triple negative breast cancer treated with anthracyclinebased neoadjuvant chemotherapy / C. Criscitiello, M.A.B.. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 28:suppl. 5(2017), pp. 217O.v68-217O.v68. (42. ESMO Madrid 2017) [10.1093/annonc/mdx364].
A gene signature of chemo-immunization to predict outcome in patients with triple negative breast cancer treated with anthracyclinebased neoadjuvant chemotherapy
C. Criscitiello;G. Curigliano;G. Pruneri;
2017
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
PIIS0923753420376420.pdf
accesso aperto
Tipologia:
Publisher's version/PDF
Licenza:
Creative commons
Dimensione
80.59 kB
Formato
Adobe PDF
|
80.59 kB | Adobe PDF | Visualizza/Apri |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
